$WNLV
Winvest Group Ltd

2023 Q1 Form 10-Q Financial Statement

#000182912623003603 Filed on May 19, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $110.2K
YoY Change
Cost Of Revenue $68.48K
YoY Change
Gross Profit $41.73K
YoY Change
Gross Profit Margin 37.86%
Selling, General & Admin $696.5K $150.0K
YoY Change 364.28% -93.94%
% of Gross Profit 1669.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $696.5K $150.0K
YoY Change 364.29% -93.94%
Operating Profit -$654.8K -$150.0K
YoY Change 336.48%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$654.8K -$150.0K
YoY Change 336.47% -93.94%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$654.8K -$150.0K
YoY Change 336.48% 1879.9%
Net Earnings / Revenue -594.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.04 -$9.086K
COMMON SHARES
Basic Shares Outstanding 17.47M
Diluted Shares Outstanding 17.47M

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.67K
YoY Change
Cash & Equivalents $93.67K
Short-Term Investments
Other Short-Term Assets $9.930K
YoY Change
Inventory
Prepaid Expenses $9.931K
Receivables $44.38K
Other Receivables $0.00
Total Short-Term Assets $148.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $1.025M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $148.0K
Total Long-Term Assets $0.00
Total Assets $148.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $36.34K $23.23K
YoY Change 56.42%
Accrued Expenses $14.48K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $679.9K $241.3K
YoY Change 181.75% 398.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $830.7K $264.5K
YoY Change 214.02% 446.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $830.7K $264.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $830.7K $264.5K
YoY Change 214.02% 446.01%
SHAREHOLDERS EQUITY
Retained Earnings -$104.5M
YoY Change
Common Stock $17.53K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$682.7K -$264.5K
YoY Change
Total Liabilities & Shareholders Equity $148.0K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$654.8K -$150.0K
YoY Change 336.48% 1879.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$61.53K -$132.8K
YoY Change -53.65% 906.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $118.0K 132.8K
YoY Change -11.07% 906.44%
NET CHANGE
Cash From Operating Activities -$61.53K -132.8K
Cash From Investing Activities 0.000
Cash From Financing Activities $118.0K 132.8K
Net Change In Cash $56.52K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$61.53K -$132.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001558740
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Revenues
Revenues
usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56204
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
WINVEST GROUP LTD.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2052033
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
50 West Liberty Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 880
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89501
CY2023Q1 dei City Area Code
CityAreaCode
(775)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
996-0288
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17526075 shares
CY2023Q1 us-gaap Cash
Cash
93670 usd
CY2022Q4 us-gaap Cash
Cash
37148 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44378 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28147 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9931 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
155354 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
147979 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
220648 usd
CY2023Q1 us-gaap Assets
Assets
147979 usd
CY2022Q4 us-gaap Assets
Assets
220648 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
36336 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23746 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14484 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21040 usd
CY2023Q1 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
46538 usd
CY2023Q1 wnlv Notes Payable Related Partie Classified Current
NotesPayableRelatedPartieClassifiedCurrent
633339 usd
CY2022Q4 wnlv Notes Payable Related Partie Classified Current
NotesPayableRelatedPartieClassifiedCurrent
561830 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
830698 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
706615 usd
CY2023Q1 us-gaap Liabilities
Liabilities
830698 usd
CY2022Q4 us-gaap Liabilities
Liabilities
706615 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17526075 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17526075 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17411217 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
17526 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17411 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103571797 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103113871 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104499880 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103845089 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-682719 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147979 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220648 usd
CY2023Q1 us-gaap Revenues
Revenues
110209 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68479 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
41729 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
656328 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150017 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
40193 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
696521 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
150017 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-654791 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-150017 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654791 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-150017 usd
CY2023Q1 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2022Q1 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.01
CY2023Q1 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
17476303 shares
CY2022Q1 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
16511217 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-114522 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-150017 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-264539 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
458040 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-654791 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-682719 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654791 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-150017 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
458040 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16231 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-145422 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12590 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17264 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6555 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61526 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132753 usd
CY2023Q1 wnlv Loan Proceeds
LoanProceeds
-46538 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
80000 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
151510 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
132753 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118048 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132753 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
56522 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37148 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93670 usd
CY2012Q1 wnlv Issuance Of Common Stock For Donated Service
IssuanceOfCommonStockForDonatedService
98984744 shares
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 250
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 250
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
114510 shares
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2023Q1 wnlv Working Capital Deficit
WorkingCapitalDeficit
682719 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104499880 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zGybEHWRSAw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zRrhMnAVSKb4">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities at the date of the financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1810116 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
93670 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
37148 usd
CY2023Q1 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
46538 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
458040 usd
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
855000 shares
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
855000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3420 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2023Q1 wnlv Issuance Of Common Stock For Acquistions
IssuanceOfCommonStockForAcquistions
1980000 usd
CY2023Q1 wnlv Net Liabilities Assumed
NetLiabilitiesAssumed
55288 usd
CY2023Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
2035288 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
29241 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
2637 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
31878 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
26916 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
87166 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
55288 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
30000 usd
CY2023Q1 us-gaap Share Price
SharePrice
2.20
CY2023Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
2035288 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1024799 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1010489 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17526075 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17526075 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17411217 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17411217 shares
CY2023Q1 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
633139 usd
CY2022Q4 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
561830 usd
CY2023Q1 wnlv Project Advances
ProjectAdvances
100000 usd
CY2022Q4 wnlv Project Advances
ProjectAdvances
100000 usd
CY2023Q1 us-gaap Other Commitment
OtherCommitment
0 usd
CY2022Q4 us-gaap Other Commitment
OtherCommitment
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
227838680 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
227838680 shares
CY2023Q1 us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Each share of preferred stock is convertible to 50 shares of common stock

Files In Submission

Name View Source Status
0001829126-23-003603-index-headers.html Edgar Link pending
0001829126-23-003603-index.html Edgar Link pending
0001829126-23-003603.txt Edgar Link pending
0001829126-23-003603-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
winvestgroup_10q.htm Edgar Link pending
winvestgroup_ex31-1.htm Edgar Link pending
winvestgroup_ex31-2.htm Edgar Link pending
winvestgroup_ex32-1.htm Edgar Link pending
winvestgroup_ex32-2.htm Edgar Link pending
wnlv-20230331.xsd Edgar Link pending
wnlv-20230331_def.xml Edgar Link unprocessable
wnlv-20230331_cal.xml Edgar Link unprocessable
wnlv-20230331_lab.xml Edgar Link unprocessable
wnlv-20230331_pre.xml Edgar Link unprocessable
winvestgroup_10q_htm.xml Edgar Link completed